The Neuromuscular Disease Foundation
Donations deductibleThe Neuromuscular Disease Foundation's network
10 people2 organisationsi10 people and 2 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (10). Violet dotted lines (2) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
10 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 3 voting members of its governing body on its latest Form 990 Part VI; we list 10 in Part VII (Part VII does not always name every voting member).| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Amy Curran | Director | 2023 | 3 yrs |
| Coleman Kennedy | CEO | 2024 | 2 yrs |
| David Dahl | Director | 2021 | 5 yrs |
| David Golden | CFO | 2024 | 2 yrs |
| David Haverim | Director | 2021 | 5 yrs |
| Isabella Tyszler | Director | 2023 | 3 yrs |
| Navid Rachman | Director | 2023 | 3 yrs |
| Suma Rao-Gupta | Director | 2023 | 3 yrs |
| Tahseen Mozaffar | Director | 2019 | 7 yrs |
| Tara Voogel | Company secretary | 2023 | 3 yrs |
Under 5 years5 to 6 years6 years or more
Officers and senior leadership
3 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Geoffrey Gee | Executive Director | since 2021 |
| Lale Jackson Welsh | CEO | since 2018 |
| Nancy Lurie | Dir of Oper | since 2018 |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Navid Rachman | Director | 1 | $0 | ||
| Tara Voogel | Secretary | 1 | $0 | ||
| Amy Curran | Director | 1 | $0 | ||
| Tahseen Mozaffar | Director | 1 | $0 | ||
| Coleman Kennedy | CEO | 1 | $0 | ||
| David Golden | CFO | 1 | $0 | ||
| Suma Rao-Gupta | Director | 1 | $0 | ||
| David Haverim | Director | 1 | $0 | ||
| Isabella Tyszler | Director | 1 | $0 | ||
| David Dahl | Director | 1 | $0 |
No pay was reported for anyone in Part VII on this return.
Colorado roster
13 listediOfficers, directors and trustees from the latest filing with the Colorado Secretary of State (document 20213030477). Titles are as filed; some entries are registered agents or custodians of records rather than board members. Source: data.colorado.gov, public domain.| Name | Title as filed |
|---|---|
| Jason Taban | Board Member |
| Maria Montgomery | Board Member |
| David Haverim | Board Member |
| Nancy Lurie | Chief Operating Officer |
| Tahseen Mozaffar | Board Member |
| Rachel Leib | Media & Operations Manager |
| Carolyn Yashari Becher | Secretary |
| David Dahl | Treasurer |
| Lalé Welsh | CEO/Executive Director |
| Ralph Loren | Co-Chair |
| Tricia Mullins | Co-Chair |
| Alex Monsef | Board Member |
| David Dahl |
About
- Legal name
- The Neuromuscular Disease Foundation
- EIN
- 061789643
- Address
- 269 S Beverly Dr, Beverly Hills, CA, 90212-3807
- State
- California
- Mission
- THE NEUROMUSCULAR DISEASE FOUNDATIONS (NDF) MISSION mission is to enhance the quality of the lives of people living with GNE Myopathy (also known as HIBM) through advocacy, education, outreach, and funding for critical research focused on treatments and a cure. (as filed on the Form 990)
- Activity (NTEE)
- G12 Voluntary health associations and medical disciplines
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Voluntary Health Associations & Medical Disciplines
- Size band
- 5 (IRS master file code)
- Formed
- 2006
- Principal officer
- Coleman Kennedy (as named on the Form 990)
- IRS ruling date
- 1 January 2007
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 7, latest 2024
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥7years on the filingsTahseen Mozaffar
≥5years on the filingsDavid Dahl
≥5years on the filingsDavid Haverim
≥3years on the filingsAmy Curran
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $660k
- Total liabilities
- $1k
- Net assets or fund balances
- $659k
- Contributions and grants received
- $27k
- Program service revenue
- $0
- Grants and similar paid out
- $188k
- Employees
- 0
- Volunteers
- 10
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $65k | $352k | Deficit $287k |
As filed on the IRS Form 990. US dollars.
Grants paid
3 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| Abigail Wexner Research Inst | Research Genetic Disorders | $49k |
| University of Washington | Research Genetic Disorders | $33k |
| Yale University | Research Genetic Disorders | $32k |